Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dinoprost is a naturally occurring prostaglandin F2 alpha (PGF2α) that acts as a potent agonist at the prostanoid FP receptor. In human medicine, it is primarily used for the induction of labor, termination of pregnancy (abortion) during the second trimester, and the management of postpartum hemorrhage due to its ability to stimulate strong myometrial contractions. In veterinary medicine, dinoprost is widely utilized for luteolysis and estrus synchronization in livestock such as cattle, swine, and horses. Beyond its reproductive applications, dinoprost exerts effects on other smooth muscles, notably causing bronchoconstriction (particularly in asthmatic patients) and influencing intraocular pressure, which led to the development of prostaglandin analogs for glaucoma treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dinoprost.